36 participants
Programmed Cell Death Protein-1 (PD-1) Monoclonal Antibody for EBV-HLH and CAEBV as First-line Therapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-09-09
- Start Date:
- 2021-05-15
- Completion:
- 2023-04-30
Conditions
- EBV Infection
Interventions
- DRUG
No Results Yet